ArticleJournal of cancer research and clinical oncology2026
Efficacy and safety of transarterial chemoembolization (TACE) with tislelizumab and tyrosine kinase inhibitors versus TACE for intermediate and advanced HCC.
Saikang Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.